These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22427053)

  • 61. Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.
    He S; Miao X; Wu Y; Zhu X; Miao X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Wang Y; Xu X
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):561-72. PubMed ID: 26498772
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chibby is a weak regulator of β-catenin activity in gastric epithelium.
    Li FQ; Chiriboga L; Black MA; Takemaru KI; Raffaniello RD
    J Cell Physiol; 2019 Feb; 234(2):1871-1879. PubMed ID: 30063079
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
    Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
    Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
    [TBL] [Abstract][Full Text] [Related]  

  • 64. XPNPEP3 is a novel transcriptional target of canonical Wnt/β-catenin signaling.
    Kumar R; Kotapalli V; Naz A; Gowrishankar S; Rao S; Pollack JR; Bashyam MD
    Genes Chromosomes Cancer; 2018 Jun; 57(6):304-310. PubMed ID: 29383790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
    Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
    Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The cadherin-catenin complex in nasopharyngeal carcinoma.
    Galera-Ruiz H; Ríos MJ; González-Cámpora R; de Miguel M; Carmona MI; Moreno AM; Galera-Davidson H
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1335-41. PubMed ID: 21240516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor.
    Hu Z; Müller S; Qian G; Xu J; Kim S; Chen Z; Jiang N; Wang D; Zhang H; Saba NF; Shin DM; Chen ZG
    Cancer; 2015 Jan; 121(2):214-25. PubMed ID: 25209444
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased expression of the spindle checkpoint protein BubR1 is associated with high cell proliferation in primary gastrointestinal diffuse large B cell lymphoma.
    Chen F; Yang G; Xia B
    Cell Biochem Biophys; 2013 Jul; 66(3):747-52. PubMed ID: 23400934
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gliosarcomas lack BRAF
    Schwetye KE; Joseph NM; Al-Kateb H; Rich KM; Schmidt RE; Perry A; Gutmann DH; Dahiya S
    Neuropathology; 2016 Oct; 36(5):448-455. PubMed ID: 26932501
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
    Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
    J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nuclear F-actin enhances the transcriptional activity of β-catenin by increasing its nuclear localization and binding to chromatin.
    Yamazaki S; Yamamoto K; de Lanerolle P; Harata M
    Histochem Cell Biol; 2016 Apr; 145(4):389-99. PubMed ID: 26900020
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CCN family member 2/connective tissue growth factor (CCN2/CTGF) is regulated by Wnt-β-catenin signaling in nucleus pulposus cells.
    Hiyama A; Morita K; Sakai D; Watanabe M
    Arthritis Res Ther; 2018 Sep; 20(1):217. PubMed ID: 30268161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.